APA (7th ed.) Citation

George, G., Rowley, M., Coolen, A., Olalla, A. S., Hammar, N., Feychting, M., . . . Hemelrijck, M. V. Advanced risk signature analysis of inflammation markers in predicting prostate cancer using the Swedish Apolipoprotein-related MOrtality RISk (AMORIS) cohort. Elsevier.

Chicago Style (17th ed.) Citation

George, G., M. Rowley, A.C.C Coolen, A. Santa Olalla, N. Hammar, M. Feychting, S.N Karagiannis, D. Enting, and M. Van Hemelrijck. Advanced Risk Signature Analysis of Inflammation Markers in Predicting Prostate Cancer Using the Swedish Apolipoprotein-related MOrtality RISk (AMORIS) Cohort. Elsevier.

MLA (9th ed.) Citation

George, G., et al. Advanced Risk Signature Analysis of Inflammation Markers in Predicting Prostate Cancer Using the Swedish Apolipoprotein-related MOrtality RISk (AMORIS) Cohort. Elsevier.